Becoming a Payvider

The payvider model, in which a health system owns or operates a Medicare Advantage plan, is not new. Kaiser Permanente has operated this way since the managed care era began. What is new is the policy environment that has made the model structurally advantaged over traditional arrangements between independent insurers and independent delivery systems.

Rate compression, encounter-based risk adjustment, ACO maturation, and dual eligible integration requirements all converge to favor entities that control both the coverage mechanism and the care delivery apparatus. The CY 2027 MA rate announcement proposed a 0.09 percent growth rate, continuing the pressure on plan margins that began with the 2024 and 2025 rate cycles. The impending chart review exclusion removes revenue that payviders never depended on while eliminating a source of income that independent plans have built their risk adjustment strategies around.

This article examines what a payvider is, why the current policy environment advantages the model, and what the conversion pathway from ACO to plan ownership looks like for health systems considering the transition.

What a Payvider Is

#

A payvider is a health system that owns or operates a licensed health plan, typically a Medicare Advantage plan, alongside its provider operations. The defining characteristic is shared ownership or control over both sides of the payment-delivery transaction.

The established payviders demonstrate the range of organizational structures the model encompasses. Kaiser Permanente operates fully integrated delivery systems in multiple regions where plan membership and care delivery are unified by design. UPMC in Pennsylvania runs one of the largest academic medical centers in the country alongside a substantial MA plan. Geisinger, now part of Kaiser’s Risant Health subsidiary, built its reputation on integrated care delivery in rural Pennsylvania. Intermountain Health in Utah combines a major health system with SelectHealth’s insurance operations. CareOregon operates as a provider-owned health plan serving Medicaid and Medicare populations in Oregon. Providence, operating across multiple western states, has grown its health plan enrollment by over 70 percent in the past decade.

Approximately 300 health systems now operate their own health plans. The category is no longer a niche occupied by a handful of integrated systems; it is a growing segment of the MA market.

What distinguishes payviders from other organizational arrangements requires precision. A health system that contracts closely with an MA plan through a value-based arrangement is not a payvider; that is a contracted relationship with shared incentives but separate ownership. An ACO is not a payvider; that is population health management within fee-for-service, with shared savings but without plan licensure. A health system with a narrow network MA contract where it serves as the exclusive or preferred provider is not a payvider; that is network design, not ownership integration.

The payvider distinction matters because ownership alignment changes incentives, data flows, and operational integration in ways that contractual arrangements cannot fully replicate. When the plan and the delivery system share a balance sheet, the medical loss ratio is not a cost to be minimized but an internal transfer to be optimized.

The Encounter-Based Risk Adjustment Advantage

#

The transition to encounter-based risk adjustment creates a structural advantage for payviders that will widen as the chart review exclusion takes effect.

Payviders control both sides of the documentation-to-encounter-data pipeline. The clinician who assesses and documents a condition works for the same entity that submits the encounter data and receives the risk-adjusted payment. There is no arm’s-length clinical documentation improvement program, no third-party chart review contractor, no retrospective mining of medical records to find codes that were not captured at the point of care.

Risk capture in a payvider happens at the point of care, documented in the entity’s own electronic health record, submitted through its own encounter data systems, and validated by its own compliance infrastructure. The coding query that flags a patient for condition assessment at an upcoming visit is an internal care coordination function, not an external contractor seeking documentation to support a retrospective code submission.

This operational integration matters under chart review exclusion. When CMS finalizes the proposal to exclude diagnoses from unlinked chart review records from risk score calculation, plans that have relied heavily on chart review will face a revenue cliff. Estimates suggest that unlinked chart review contributions to MA risk scores vary widely by plan, with some plans deriving 5 percent or more of their risk scores from this source.

Payviders are structurally insulated from this impact because their risk capture was always encounter-based. A payvider that never submitted unlinked chart review records loses nothing from their exclusion. A payvider whose documentation completeness at the point of care has been consistently high enters the post-chart-review environment with its risk score generation capacity intact.

The compliance dimension reinforces the advantage. Payviders face a simpler governance landscape for documentation integrity. The compliance question is whether internal clinical documentation meets standards, not whether external coding contractors are staying on the right side of the line between legitimate CDI support and inappropriate coding pressure. The separation between plan and provider that creates compliance friction in traditional arrangements does not exist when the plan and provider are the same entity.

Rate Compression Resilience

#

The 0.09 percent CY 2027 MA rate growth proposal follows a 5.06 percent increase in 2026 and a 3.7 percent increase in 2025. The directional trend is clear: the historically generous MA rate environment is normalizing toward tighter margins. For plans operating at high medical loss ratios with thin administrative margins, rate compression forces difficult choices between benefit reductions, market exits, and operational restructuring.

Payviders experience rate compression differently because of the shared balance sheet. When a national insurer’s medical loss ratio deteriorates in a given county, the response options are to cut benefits, raise premiums within regulatory limits, or exit the county. The medical loss is a cost flowing to an external delivery system; reducing it requires either paying providers less or reducing utilization.

When a payvider’s plan-level medical loss ratio deteriorates, the response can include internal cost management and delivery system efficiency. The medical loss is an internal transfer from the plan entity to the provider entity. The combined enterprise can accept a lower plan-level margin if the delivery system captures the volume and the consolidated entity remains financially viable.

This creates a fundamentally different exit calculus. A national insurer evaluates each county as an independent line item and exits counties where profitability cannot be restored within acceptable timelines. A payvider evaluates the plan and the delivery system together. The county where the plan loses money may be the county where the hospital draws its largest patient volume. Exiting the plan market means potentially losing patients to competing plans while the delivery system remains tied to the geography.

The result is that payviders tend to have more staying power in markets under margin pressure than independent plans operating the same markets. This stability advantage compounds over time: as independent plans exit marginal counties, remaining plans gain enrollment share, and payviders positioned in those markets expand their coverage footprint without acquisition costs.

The ACO-to-Payvider Pipeline

#

A high-performing ACO has already built much of the infrastructure that payvider operations require. Population health management systems, risk stratification capabilities, care coordination workforce, attributed patient relationships, and performance under downside risk are all prerequisites for successful plan operation that ACO participation develops.

The conversion from ACO to payvider is a concrete strategic progression, not a speculative leap. An MSSP ACO that has generated shared savings across multiple performance years has demonstrated the cost management capability that underlies plan-level profitability. Adding a plan license converts the ACO’s fee-for-service population health infrastructure into a platform for capitated plan operations.

The conversion pathway includes several distinct requirements. State insurance licensing involves meeting capital requirements, filing actuarial documentation, and obtaining regulatory approval to operate as a licensed insurer. Capital requirements vary by state but typically require demonstrating the financial reserves necessary to cover claims obligations. The actuarial capacity to develop competitive bids, set appropriate premiums, and maintain statutory reserves can be built internally or contracted through actuarial consulting relationships. Network adequacy standards require demonstrating access to providers beyond the health system’s own facilities, which may necessitate contracting with external specialists, facilities, and ancillary providers. The CMS Part C and Part D application process involves timeline constraints, operational readiness demonstrations, and approval contingencies.

The scale threshold for viable plan ownership is not fixed, but the economics point toward minimum attributed population sizes in the range of 5,000 to 10,000 Medicare beneficiaries for a new plan to achieve operational sustainability. ACOs with larger attributed populations and more extensive service area coverage face lower per-member administrative cost burdens and more diversified risk pools.

The performance threshold matters as much as scale. An ACO that has not demonstrated shared savings generation should not assume that plan ownership will produce better results. Plan operations add administrative complexity, actuarial requirements, and regulatory obligations that ACO participation does not involve. An ACO that struggles under MSSP will not find payvider operations easier.

Market conditions also affect conversion viability. Counties with high MA penetration and intense plan competition present different entry dynamics than markets with limited plan options. The presence of existing payviders in a market affects competitive positioning. The AHEAD model’s state-level global budget structure, launching in eight states with Maryland’s transition to Geo AHEAD, creates geographic variation in how hospital economics interact with plan ownership strategies.

The Dual Eligible FIDE SNP Advantage

#

Fully integrated dual eligible special needs plans represent a particularly strong fit for the payvider model. FIDE SNPs require deep operational integration between plan and delivery system for long-term services and supports, behavioral health, care coordination, and benefit administration that spans Medicare and Medicaid.

For an independent insurer, building FIDE SNP capability means contracting with delivery systems for integrated care delivery, negotiating with states for Medicaid managed care authority, and managing the coordination complexity across two distinct benefit programs. For a payvider, FIDE SNP capability builds on existing integration. The care coordination infrastructure, the clinical workforce, and the data systems are internal. The contracting with state Medicaid agencies for dual eligible managed care authority involves fewer external dependencies.

The policy environment increasingly favors FIDE SNP and highly integrated dual eligible coverage. The Financial Alignment Initiative demonstrations concluded in 2025, and states that participated are transitioning to FIDE SNP or other integrated models. The monthly integrated care special enrollment period, which allows dual eligible beneficiaries to switch to integrated plans at any time, creates enrollment fluidity that favors plans with strong integration capabilities. C-SNP enrollment overall continues to grow as CMS encourages plans to develop specialized capabilities for complex populations.

For health systems considering payvider conversion, the dual eligible opportunity is a significant factor in the strategic case. FIDE SNP development requires capabilities that independent plans cannot easily replicate through contracting alone. Health systems with existing LTSS capacity, behavioral health integration, and care coordination workforce have a head start that translates directly into FIDE SNP competitive advantage.

The Build, Buy, or Partner Decision

#

Health systems evaluating the payvider pathway face three strategic options. Building a plan from scratch involves obtaining licensure, developing actuarial and administrative capabilities, and growing enrollment organically. Acquiring an existing plan license through merger or asset purchase accelerates time to market but requires integration of potentially misaligned operational systems. Partnering with a regional plan through shared-risk arrangements creates some payvider economics without full ownership integration.

Building requires patience and capital. The plan application and approval process takes 12 to 18 months under normal CMS processing timelines. Actuarial, compliance, and administrative infrastructure must be developed before operations begin. Enrollment growth from a standing start is slow, and the plan will likely operate at a loss in early years as fixed administrative costs are spread across a small membership base.

Acquiring offers speed but integration complexity. Existing plan licenses come with enrolled populations, provider networks, and operational systems that may not align with the health system’s clinical operations. The integration work to unify claims systems, credentialing processes, quality reporting, and member services can absorb substantial management attention and capital.

Partnership models offer intermediate options. Shared-risk arrangements between health systems and regional plans can create economic alignment similar to payvider integration without requiring full plan ownership. These arrangements may serve as stepping stones toward eventual acquisition or as permanent structures for systems that lack the scale or capital for independent plan operations.

The right choice depends on the health system’s market position, capital availability, ACO maturity, and strategic timeline. Systems with established ACO performance, strong regional market share, and access to capital are better positioned for build or buy strategies. Systems with less developed population health infrastructure or capital constraints may find partnership models more appropriate as initial steps.

What Sustainable Medicare Advantage Looks Like

#

The convergence of rate compression, encounter-based risk adjustment, dual eligible integration, and ACO maturation points toward the payvider model as the most viable long-term operating structure for Medicare Advantage in competitive markets.

This does not mean every health system should become a payvider. The capital, actuarial, and regulatory requirements are substantial. Systems without sufficient scale, ACO experience, or market position may find the conversion pathway too risky or resource-intensive. For these systems, contracting with existing plans under value-based arrangements, participating in MSSP or ACO REACH successor models, and building toward payvider readiness over longer time horizons may be more appropriate strategies.

But for health systems with scale, demonstrated population health management capability, and competitive market positions, the strategic case for plan ownership has strengthened under current policy conditions. The advantages that payviders enjoy under encounter-based risk adjustment, rate compression resilience, dual eligible integration requirements, and ACO-to-plan conversion pathways are not temporary. They reflect structural features of the policy environment that are unlikely to reverse.

The MA overpayment context reinforces this conclusion. CMS continues to pursue payment accuracy through risk model updates, chart review exclusion, and coding intensity adjustments. Plans that built revenue models around aggressive coding practices face the most exposure to these corrections. Payviders whose risk capture was always encounter-based, whose documentation integrity was always internal, and whose coding practices were always tied to clinical encounters are better positioned to maintain stable revenue under payment accuracy reforms.

The question for health system leadership is not whether the payvider model is strategically advantaged but whether their organization has the prerequisites to pursue it successfully and the patience to build the capabilities required for sustainable plan operations.

Related Reading

#

MCR-02_04 The Encounter-Based Risk Adjustment Future MCR-02_01 The 0.09% Shock: What CMS Actually Proposed for 2027 MCR-04_01 Is MA Still Worth It? The Strategic Recalculation for Insurers MCR-12_02 Health System Winners and Losers: Kaiser, Intermountain, UPMC, Advocate, Geisinger